Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,210 | 22,962 | 21,091 | 38,388 | 53,025 |
| Marketable Securities | 21,934 | 26,583 | 64,028 | 33,759 | 42,510 |
| Receivables | 100 | N/A | N/A | N/A | N/A |
| TOTAL | $31,925 | $50,803 | $86,985 | $74,768 | $97,950 |
| Non-Current Assets | |||||
| PPE Net | 1,270 | 1,853 | 2,280 | 1,421 | 1,793 |
| Investments And Advances | 0 | 0 | 0 | 4,002 | 29,814 |
| Other Non-Current Assets | 2,993 | 90 | 90 | 333 | 118 |
| TOTAL | $4,263 | $1,943 | $2,370 | $5,756 | $31,725 |
| Total Assets | $36,188 | $52,746 | $89,355 | $80,524 | $129,675 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 7,767 | 5,012 | 339 | 3,366 |
| Accounts payable and accrued liabilities | 847 | 1,040 | 2,276 | 2,606 | 3,872 |
| Accrued Expenses | 2,376 | 2,026 | 3,103 | 5,450 | 4,595 |
| Other current liabilities | 208 | N/A | N/A | N/A | N/A |
| TOTAL | $12,923 | $10,833 | $10,391 | $8,525 | $12,148 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 8,263 | 14,719 | 9,198 | 1,776 |
| Deferred Revenues | N/A | N/A | N/A | 130 | 315 |
| Other Non-Current Liabilities | 2,399 | 0 | 0 | 0 | 571 |
| TOTAL | $2,239 | $8,263 | $14,719 | $9,198 | $2,477 |
| Total Liabilities | $15,162 | $19,096 | $25,110 | $17,723 | $14,625 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,352 | 2,482 | 2,128 | 1,696 | 1,691 |
| Common Shares | 4 | 2 | 30 | 24 | 24 |
| Retained earnings | -322,304 | -298,701 | -264,186 | -215,979 | -158,124 |
| Other shareholders' equity | -200 | -60 | -120 | -76 | -171 |
| TOTAL | $21,026 | $33,650 | $64,245 | $62,801 | $115,050 |
| Total Liabilities And Equity | $36,188 | $52,746 | $89,355 | $80,524 | $129,675 |